Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213809-19-000061
Filing Date
2019-08-13
Accepted
2019-08-13 16:24:17
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q 2Q 2019 DYAI q2201910-qdyai.htm 10-Q 842297
2 EXHIBIT 31.1 exhibit311certifications-m.htm EX-31.1 18395
3 EXHIBIT 31.2 exhibit312certifications-p.htm EX-31.2 17251
4 EXHIBIT 32.1 exhibit321sectopm1350certi.htm EX-32.1 9944
5 EXHIBIT 32.2 exhibit322sectopm1350certi.htm EX-32.2 9941
12 dyadiclogoa05.jpg GRAPHIC 16790
  Complete submission text file 0001213809-19-000061.txt   5175114

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dyai-20190630.xml EX-101.INS 1154941
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyai-20190630.xsd EX-101.SCH 39972
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyai-20190630_cal.xml EX-101.CAL 63918
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyai-20190630_def.xml EX-101.DEF 164999
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyai-20190630_lab.xml EX-101.LAB 522817
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyai-20190630_pre.xml EX-101.PRE 290693
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

IRS No.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32513 | Film No.: 191020946
SIC: 2836 Biological Products, (No Diagnostic Substances)